跳至主要内容
临床试验/JPRN-UMIN000026581
JPRN-UMIN000026581已完成未知

The study about the effects of cholesterol absorption inhibition on coronary artery plaque in patients treated with PCI - The effects of ezetimibe on coronary plaque

Kurume University Medical Center0 个研究点目标入组 50 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) prior taking ezetimibe, 2) recent acute coronary syndrome (< 1 year), 3) renal insufficiency (serum creatinine > 2.0 mg / dL), 4) hepatic dysfunction (serum AST or ALT > 3-folds of standard value), 5) cancer, 6) autoimmune diseases, 7) impossibility in decision making 8) consideration as inadequate to participating in the study by attending physician.

研究者

相似试验

The study about the effects of cholesterol... | 临床试验